We conducted an analysis to examine the correlation between the richness indices (logChao1) of BCR repertoires in patients with B-ALL and various clinical features, including immune types, risk stratification, MRD levels at day 19 (D19MRD), and the presence of different fusion genes. This evidence concerns the gene BCR and acute lymphoblastic leukemia.